ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,307.01
-0.27%
US Tech 100
18,228.40
0.00%
Dow Jones
39,671.04
-0.51%
Brent Oil
81.645
0.14%
Bitcoin
69,709.66
0.88%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Hollis-Eden Pharmaceuticals (MM) (HEPH)

  7. Hollis-Eden Pharmaceuticals (MM) (HEPH) News

HEPH

Hollis-Eden Pharmaceuticals (MM) (HEPH)

Hollis-Eden Pharmaceuticals (MM)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:HEPH
DateTimeSourceHeadlineSymbolCompany
02/17/20104:03PMPR Newswire (US)Hollis-Eden Announces Name Change to Harbor BioSciences, Inc. and Ticker Symbol Change to 'HRBR'NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
02/16/20104:27PMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
02/03/20102:39PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
02/03/20102:38PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
02/03/20102:37PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
02/03/20102:37PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
02/03/20102:36PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
02/03/20102:35PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
02/03/20102:35PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
01/06/20104:31PMEdgar (US Regulatory)Securities Registration Statement (simplified form) (S-3/A)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
12/22/20094:38PMEdgar (US Regulatory)Securities Registration Statement (simplified form) (S-3)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
12/15/20096:03AMEdgar (US Regulatory)Securities Registration (section 12(b)) (8-A12B)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
11/16/20099:00AMPR Newswire (US)Hollis-Eden Presents New Interim Data From Prostate Cancer Phase I/II Clinical Studies of Apoptone (HE3235) at AACR Molecular TaNASDAQ:HEPH
11/12/20094:37PMPR Newswire (US)Hollis-Eden to Present Interim Data From Its Phase I/II Clinical Studies of Apoptone(R) (HE3235) at Molecular Targets and CancerNASDAQ:HEPH
11/06/20095:23PMEdgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
10/22/20096:05AMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
10/20/20099:11AMPR Newswire (US)Hollis-Eden Pharmaceuticals Retains Burrill LLC to Provide Exclusive Advisory Services for Lead ProgramsNASDAQ:HEPH
09/16/20091:33PMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
09/16/20098:30AMPR Newswire (US)Hollis-Eden Pharmaceuticals Receives NASDAQ Notification Related to Minimum Bid PriceNASDAQ:HEPH
08/14/20096:06AMEdgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
06/15/20093:52PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
06/15/200912:30PMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
06/15/20097:05AMPR Newswire (US)Hollis-Eden Pharmaceuticals Announces Appointment of Dr. James M. Frincke President and CEONASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
06/11/20094:54PMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
06/05/20094:06PMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
05/14/20096:03AMEdgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
05/07/20095:00PMEdgar (US Regulatory)Proxy Statement (definitive) (DEF 14A)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
04/23/20095:00PMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
03/31/20095:36PMBusiness WireHollis-Eden Pharmaceuticals Reports Fourth Quarter and Year-End 2008 Financial ResultsNASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
03/31/20095:30PMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
 Showing the most relevant articles for your search:NASDAQ:HEPH

Your Recent History

BIT
UI215B
Unicredit Bank
EU
PTTAN
La Poste 1.375% until 21...
TSXV
PNRL
Premium Nickel Resources
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved